Shoulder Innovations Launches Next-Gen InSet® Go Glenoid Implant…

Event summary

Shoulder Innovations initiated a limited user release of the InSet® Go glenoid implant for anatomic shoulder arthroplasty procedures on October 8, 2026.
The first surgical case using the InSet® Go was performed by Robert Gillespie, MD, at University Hospitals Cleveland Medical Center.
The InSet® Go maintains the original design principle of preserving bone and maximizing implant stability while streamlining the operating room experience.
The next-generation implant incorporates additional intellectual property protecting key technical components of clinical success.

The big picture

Shoulder Innovations' launch of the InSet® Go glenoid implant builds on its decade-long track record in shoulder arthroplasty, addressing the critical issue of glenoid implant loosening. The company's focus on procedural efficiency and clinical outcomes aligns with broader industry trends toward minimally invasive and patient-centric surgical solutions. The success of the InSet® Go could further solidify Shoulder Innovations' position in the competitive shoulder surgical care market.

What we're watching

Commercial Adoption: The pace at which the InSet® Go gains traction among surgeons and medical centers will determine its market penetration.
Operational Efficiency: Whether the streamlined procedure times and reduced surgical steps translate into meaningful operational efficiencies for care facilities.
Clinical Outcomes: How the long-term clinical outcomes of the InSet® Go compare to existing solutions, particularly in terms of implant stability and patient satisfaction.